Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes
- Conditions
- Metabolic ControlType 2 Diabetes
- Registration Number
- NCT04501991
- Lead Sponsor
- University of Pisa
- Brief Summary
The strict rules applied in Italy during the recent COVID-19 pandemic, with the prohibition to attend any regular outdoor activity, are likely to influence the degree of metabolic control of patients with type 2 diabetes. The aim of this observational, prospective, single centre study was to evaluate the immediate impact of the lockdown rules on the metabolic profile of a cohort of patients with type 2 diabetes.
- Detailed Description
All the patients with type 2 diabetes who were previously scheduled for a follow-up visit in our outpatient diabetes clinic during the lockdown for COVID-19 (March 9, 2020-May 04, 2020) were contacted by phone. Patients who accepted to take part of the study received a medical prescription for routine analysis via email. They were asked to perform blood drawing one week after the end of the lockdown period and transmitted us the results.
We then compared the metabolic profile tested one week after the end of the lockdown with the last value and the mean of the last three determinations performed before the pandemic emergency.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 114
- type 2 diabetes
- at least two previous clinical records in the last two years
- age >85 years
- first access to the outpatient clinic
- type 1 diabetes
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Lipid profile One week after the end of the lockdown period Complete lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol, Triglcerydes) were expressed in mg/dl or mmol/l and were determined by standard techniques.
Glucose One week after the end of the lockdown period Blood glucose was expressed in mg/dl and was determined by standard techniques.
HbA1c One week after the end of the lockdown period HbA1c was expressed as percentage or mmol/l and was determined by standard techniques.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University of Pisa
🇮🇹Pisa, Italy
University of Pisa🇮🇹Pisa, Italy